A detailed history of Jump Financial, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Jump Financial, LLC holds 369,183 shares of MNKD stock, worth $2.19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
369,183
Previous 210,600 75.3%
Holding current value
$2.19 Million
Previous $1.1 Million 110.92%
% of portfolio
0.05%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $794,500 - $1.06 Million
158,583 Added 75.3%
369,183 $2.32 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $323,789 - $434,117
79,948 Added 61.19%
210,600 $1.1 Million
Q1 2024

May 13, 2024

BUY
$3.25 - $5.27 $424,619 - $688,536
130,652 New
130,652 $591,000
Q3 2023

Oct 21, 2024

BUY
$3.91 - $5.45 $477,371 - $665,390
122,090 Added 730.2%
138,810 $573,000
Q3 2023

Nov 07, 2023

BUY
$3.91 - $5.45 $477,371 - $665,390
122,090 Added 730.2%
138,810 $573,000
Q2 2023

Oct 21, 2024

SELL
$3.72 - $4.79 $141,054 - $181,627
-37,918 Reduced 69.4%
16,720 $68,000
Q2 2023

Aug 07, 2023

SELL
$3.72 - $4.79 $141,054 - $181,627
-37,918 Reduced 69.4%
16,720 $68,000
Q1 2023

Oct 21, 2024

SELL
$3.95 - $5.63 $616,049 - $878,066
-155,962 Reduced 74.06%
54,638 $224,000
Q1 2023

May 03, 2023

SELL
$3.95 - $5.63 $624,917 - $890,705
-158,207 Reduced 74.33%
54,638 $224,000
Q4 2022

Feb 13, 2023

SELL
$3.02 - $5.37 $13,152 - $23,386
-4,355 Reduced 2.01%
212,845 $1.12 Million
Q3 2022

Nov 07, 2022

BUY
$2.99 - $4.35 $584,545 - $850,424
195,500 Added 900.92%
217,200 $671,000
Q2 2022

Aug 09, 2022

SELL
$2.67 - $4.77 $3,204 - $5,723
-1,200 Reduced 5.24%
21,700 $83,000
Q1 2022

May 12, 2022

BUY
$2.62 - $4.45 $59,998 - $101,905
22,900 New
22,900 $84,000
Q4 2021

Feb 10, 2022

SELL
$4.05 - $5.37 $1.16 Million - $1.54 Million
-286,173 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$3.89 - $5.48 $1.11 Million - $1.57 Million
286,173 New
286,173 $1.25 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.53B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.